Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Stanford University
Biotech
Trace uses $101M series A to go after same ALS target as Lilly
Trace Medicine has launched with $101 million and a mission to treat ALS by targeting a protein that recently caught Lilly's attention
James Waldron
Nov 12, 2024 7:00am
Roche sues Stanford, Foresight Diagnostics over trade secrets
Jul 3, 2024 10:44am
Cell lines could lead to new drugs for deadly heart condition
Jun 4, 2024 2:12pm
Protease inhibitor outperforms Paxlovid protecting lungs of mice
Mar 14, 2024 6:30am
Neurostim improves cognition years after brain injury: study
Dec 5, 2023 10:27am
GLP-1 drug hydrogels could reduce shots to 3 times a year
Nov 28, 2023 11:30am
